FR2540499B1 - Derive de 5-fluoro-pyrimidine-2-yl piperazine antipsychotique - Google Patents

Derive de 5-fluoro-pyrimidine-2-yl piperazine antipsychotique

Info

Publication number
FR2540499B1
FR2540499B1 FR8401751A FR8401751A FR2540499B1 FR 2540499 B1 FR2540499 B1 FR 2540499B1 FR 8401751 A FR8401751 A FR 8401751A FR 8401751 A FR8401751 A FR 8401751A FR 2540499 B1 FR2540499 B1 FR 2540499B1
Authority
FR
France
Prior art keywords
antipsychotic
piperazine
pyrimidine
fluoro
derivative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR8401751A
Other languages
English (en)
Other versions
FR2540499A1 (fr
Inventor
Davis L Temple Jr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Co
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of FR2540499A1 publication Critical patent/FR2540499A1/fr
Application granted granted Critical
Publication of FR2540499B1 publication Critical patent/FR2540499B1/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/20—Spiro-condensed ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/56—One oxygen atom and one sulfur atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurosurgery (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
FR8401751A 1983-02-07 1984-02-06 Derive de 5-fluoro-pyrimidine-2-yl piperazine antipsychotique Expired FR2540499B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US46427583A 1983-02-07 1983-02-07

Publications (2)

Publication Number Publication Date
FR2540499A1 FR2540499A1 (fr) 1984-08-10
FR2540499B1 true FR2540499B1 (fr) 1986-09-26

Family

ID=23843239

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8401751A Expired FR2540499B1 (fr) 1983-02-07 1984-02-06 Derive de 5-fluoro-pyrimidine-2-yl piperazine antipsychotique

Country Status (5)

Country Link
JP (1) JPS59148780A (fr)
DE (1) DE3404193A1 (fr)
FR (1) FR2540499B1 (fr)
GB (1) GB2139217B (fr)
MY (1) MY8800109A (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4748240A (en) * 1987-04-03 1988-05-31 American Home Products Corporation Psychotropic bicyclic imides
US5239847A (en) * 1991-06-12 1993-08-31 Samsung Electronics Co., Ltd. Agitator for a washing machine
US5631017A (en) * 1993-03-26 1997-05-20 Beth Israel Deaconess Medical Center, Inc. Topical application of buspirone for treatment of pathological conditions associated with immune responses
US5484788A (en) * 1993-03-26 1996-01-16 Beth Israel Hospital Association Buspirone as a systemic immunosuppressant
US5637314A (en) * 1995-06-07 1997-06-10 Beth Israel Deaconess Medical Center, Inc. Topical and systemic application of buspirone or derivatives thereof for treating atopic dermatitis

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3398151A (en) * 1966-02-01 1968-08-20 Mead Johnson & Co Azaspirodecanediones and azaspiroundecanediones
BE759371A (fr) * 1969-11-24 1971-05-24 Bristol Myers Co Azaspirodecanediones heterocycliques et procedes pour leur preparation
US3976776A (en) * 1972-12-06 1976-08-24 Mead Johnson & Company Tranquilizer process employing N-(heteroarcyclic)piperazinylalkylazaspiroalkanediones
US4182763A (en) * 1978-05-22 1980-01-08 Mead Johnson & Company Buspirone anti-anxiety method

Also Published As

Publication number Publication date
JPS59148780A (ja) 1984-08-25
GB2139217B (en) 1986-07-09
DE3404193A1 (de) 1984-08-09
DE3404193C2 (fr) 1987-06-11
GB8403102D0 (en) 1984-03-07
JPH0319233B2 (fr) 1991-03-14
FR2540499A1 (fr) 1984-08-10
MY8800109A (en) 1988-12-31
GB2139217A (en) 1984-11-07

Similar Documents

Publication Publication Date Title
GB2146333B (en) Piperazine derivatives
GB2114122B (en) Piperazine derivatives
DK1491D0 (da) Nitrogenholdige heterocycliske forbindelser
DK378085D0 (da) Heterocycliske derivater
DE3469173D1 (de) Benzhydrylpiperazines
ES533084A0 (es) Derivados de cefalosporina
DK108585D0 (da) Piperazinderivater
PH18220A (en) Thiazolidinylalkylene piperazine derivatives
GB2114121B (en) Piperazine derivatives
DE3466987D1 (de) Benzothiazine derivatives
DE3476386D1 (de) Morpholine derivatives
GB2143235B (en) 1-pyridyl-alkyl-4-aryl piperazine derivatives
DK91890A (da) Piperazin-derivater
DK205684D0 (da) Morpholinderivater
FR2540499B1 (fr) Derive de 5-fluoro-pyrimidine-2-yl piperazine antipsychotique
GB2105714B (en) Spirothiazolidinyl piperazine derivatives
ZA823777B (en) Piperazine derivatives
ES532341A0 (es) Derivados de piperazina
DK96184A (da) Heterocycliske forbindelser
DK397786D0 (da) Piperazinderivater
DK253586A (da) Piperazinderivater
DK552585D0 (da) Piperazinderivater
IE831387L (en) Piperazine derivatives
IE831502L (en) Piperazine derivatives
GB8304528D0 (en) Piperazine derivatives